Veterinary Medicines

BioBos RCC, Suspension for injection

Authorised
  • Bovine coronavirus, strain C-197, Inactivated
  • Bovine rotavirus, strain TM-91, Inactivated
  • Escherichia coli, serotype O8:K35 (fimbrial adhesin F5), Inactivated
Download as PDF

Product identification

Medicine name:
BioBos RCC, injekcinė suspensija
BioBos RCC, Suspension for injection
Active substance:
  • Bovine coronavirus, strain C-197, Inactivated
  • Bovine rotavirus, strain TM-91, Inactivated
  • Escherichia coli, serotype O8:K35 (fimbrial adhesin F5), Inactivated
Target species:
  • Cattle
Route of administration:
  • Intramuscular use

Product details

Active substance and strength:
  • Bovine coronavirus, strain C-197, Inactivated
    1.00
    relative potency
    /
    1.00
    Dose
  • Bovine rotavirus, strain TM-91, Inactivated
    1.00
    relative potency
    /
    1.00
    Dose
  • Escherichia coli, serotype O8:K35 (fimbrial adhesin F5), Inactivated
    1.00
    relative potency
    /
    1.00
    Dose
Pharmaceutical form:
  • Suspension for injection
Withdrawal period by route of administration:
  • Intramuscular use
    • Cattle
      • Meat and offal
        0
        day
      • Milk
        0
        hour
Anatomical therapeutic chemical veterinary (ATCvet) codes:
  • QI02AL01
Legal status of supply:
This information is not available for this product.
Authorisation status:
  • Valid
Authorised in:
  • Lithuania
Package description:
  • Glass Vial 20 x 1.0 Dose
  • Glass Vial 10 x 1.0 Dose
  • Glass Vial 2 x 1.0 Dose
  • Plastic Vial 1 x 50.0 Dose
  • Glass Vial 1 x 50.0 Dose
  • Plastic Vial 24 x 25.0 Dose
  • Glass Vial 24 x 25.0 Dose
  • Plastic Vial 12 x 25.0 Dose
  • Glass Vial 12 x 25.0 Dose
  • Plastic Vial 1 x 25.0 Dose
  • Glass Vial 1 x 25.0 Dose
  • Plastic Vial 10 x 5.0 Dose
  • Glass Vial 10 x 5.0 Dose
  • Plastic Vial 5 x 5.0 Dose
  • Glass Vial 5 x 5.0 Dose
  • Plastic Vial 1 x 5.0 Dose
  • Glass Vial 1 x 5.0 Dose

Additional information

Entitlement type:
  • Marketing Authorisation
Legal basis of product authorisation:
  • Full application (Article 12(3) of Directive No 2001/82/EC)
Marketing authorisation holder:
  • Bioveta a.s.
Marketing authorisation date:
Manufacturing sites for batch release:
  • Bioveta a.s.
Responsible authority:
  • State Food And Veterinary Service
Authorisation number:
  • LT/2/22/2718/001-010
Date of authorisation status change:
Reference member state:
  • Czechia
Procedure number:
  • CZ/V/0176/001
Concerned member states:
  • Bulgaria
  • Croatia
  • Cyprus
  • Estonia
  • Hungary
  • Latvia
  • Lithuania
  • Malta
  • Poland
  • Romania
  • Slovakia

Documents

Summary of Product Characteristics

This document does not exist in this language (English). You can find it in another language below.
Lithuanian (PDF)
Published on: 25/01/2023
Download

PuAR Biobos RCC.pdf

English (PDF)
Published on: 29/08/2022
Download
How useful was this page?:
No votes yet
"Please do not include any personal data, such as your name or contact details. If you do, you consent to the processing of that data in accordance with EMA’s Privacy Statement concerning requests for information or access to documents. If you would like a reply from EMA, please Send a question to EMA instead."